FINOTONLIMAB
UNII 533Z4G2286

Substance Identification & Data

This profile provides standardized clinical and technical data for Finotonlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 533Z4G2286.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2350298-85-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
533Z4G2286
CAS Registry Number
2350298-85-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FINOTONLIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C170758
National Cancer Institute reference terminology for clinical and research data.
INN ID
11492
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Finotonlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FINOTONLIMAB

Common Names & Synonyms

FINOTONLIMAB [INN]
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN-MUS MUSCULUS MONOCLONAL SCT-I10A .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SCT-I10A .KAPPA.-CHAIN, DIMER
SCT I10A [WHO-DD]

Technical Codes

SCT-I10A

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus